News / Events
Home/News/Events/News / Events/Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA

Congratulations! The GCP inspection of phase I cell therapy study for chronic stroke was approval by TFDA

UPDATE : 2019/09/03
Virginia Contract Research Organization Co., Ltd.(VCRO) has successfully conducted and managed the clinical operation, data management, statistical analysis, medical writing, and GCP inspection of a phase I cell therapy IND-used study. In this clinical trial, VCRO has conquered diverse challenges the fast-paced nature of an cell therapy study, and overcame all the difficulties. On Sep-2019, the study was granted with an approval by TFDA for the GCP inspection. Just another epic VCRO milestone that we are excited to share with you!
舞狮争霸走势图 广西快乐10分 福彩开奖现场直播新浪 手机信誉棋牌游戏 雪缘园篮球即时比分 即时赔率亚洲赔率澳门赔率 棋牌游戏龙虎有规律吗 188体育注册 体球即时网 水果代购怎么赚钱 qq分分彩全天开奖网 怎么利用企查查赚钱 传奇彩票网址 西甲雪缘园 自动贩卖机可以赚钱吗 吉林快3走势图基本图 开家赚钱的小咖啡店 田口护